tiprankstipranks
Advertisement
Advertisement

Tong Ren Tang Technologies Profit Falls in 2025 as It Wraps Up 14th Five-Year Plan

Story Highlights
  • Tong Ren Tang Technologies saw 2025 revenue and net profit decline, yet kept its dividend stable while focusing on operational resilience.
  • The company advanced reforms in efficiency, cost control, and governance, aiming to strengthen its TCM position entering the 15th Five-Year Plan.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Tong Ren Tang Technologies Profit Falls in 2025 as It Wraps Up 14th Five-Year Plan

Claim 55% Off TipRanks

Tong Ren Tang Technologies Co ( (HK:1666) ) has shared an announcement.

Tong Ren Tang Technologies reported 2025 revenue of RMB6.48 billion, down 10.69% year-on-year, with net profit falling 25.51% to RMB660.63 million and earnings per share dropping to RMB0.31, while maintaining a stable dividend per share of RMB0.18. Despite the weaker financial performance in the final year of its “14th Five-Year Plan,” the group emphasized quality enhancement, cost control, and business structure optimization, claiming improved operational efficiency, stronger cash flow from operating activities, and a more streamlined, institutionalized management framework to support its transition into the next planning period.

The company highlighted progress in reform and upgrading initiatives, including enhancing production support systems, adjusting its product portfolio, and optimizing resource allocation to bolster product profitability. Management underscored that these measures have stabilized core operations, improved governance standards, and built momentum for high-quality development under the forthcoming “15th Five-Year Plan,” positioning the group more robustly within a traditional Chinese medicine industry undergoing structural adjustment and changing competitive dynamics.

The most recent analyst rating on (HK:1666) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.

More about Tong Ren Tang Technologies Co

Tong Ren Tang Technologies Co. Ltd. is a Beijing-based joint stock company specializing in the manufacturing of proprietary traditional Chinese medicine products. Listed in Hong Kong, the group focuses on key product lines and priority markets in the traditional Chinese medicine sector, emphasizing refined management, optimized product portfolios, and improved sales channel layouts to strengthen its competitive position.

Average Trading Volume: 1,146,049

Technical Sentiment Signal: Sell

Current Market Cap: HK$5.11B

For detailed information about 1666 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1